Table 1. Monitoring of clinical parameters during the study.
End point | Baseline ( n = 937) |
Month 1 ( n = 821) |
Month 3 ( n = 743) |
Month 6 ( n = 698) |
Month 9 ( n = 137) |
Month 12 ( n = 106) |
---|---|---|---|---|---|---|
Pain at rest (VAS score) | 55.9 ± 11.4 | 31.8 ± 9.7 | 24.9 ± 10.2 | 24.1 ± 9.1 | 25.3 ± 7.3 | 25.9 ± 6.9 |
Pain on movement (VAS score) | 72.1 ± 9.8 | 48.3 ± 6.7 | 38.2 ± 7.7 | 37.9 ± 7.3 | 38.4 ± 6.5 | 38.9 ± 11.5 |
WOMAC score | 56.8 ± 8.7 | 45.7 ± 7.9 | 27.6 ± 10.3 | 24.8 ± 8.8 | N/A | N/A. |
Acetaminophen/NSAIDs use | 48.8% | 27.4% | 19.4% | 19.6% | N/A | N/A |
Patient satisfaction | ||||||
Worsening (%) | 2.4 | 3.2 | 4.8 | |||
Unchanged (%) | 9.3 | 8.9 | 9.6 | |||
Improved (%) | 88.3 | 87.9 | 85.6 |
Abbreviations: N/A, not available; NSAID, nonsteroidal anti-inflammatory drug; VAS, visual analog scale; WOMAC, Western Ontario McMasters University Osteoarthritis Index.